NGM · Medical - Diagnostics & Research

Exagen Inc. (XGN) Stock

$8.42 +3.06% NGM: XGN Healthcare

Valuation

MetricValue
Price$8.42
Market Cap$203.43M
P/E Ratio-9.96
P/B Ratio16.16
P/S Ratio2.78
EPS (TTM)$-0.93
52-Week High$12.23
52-Week Low$2.59
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-121.62%
ROA-36.44%
ROCE-34.33%
Gross Margin-20.90%
Operating Margin-20.90%
Net Margin-26.61%
Debt/Equity2.09
Current Ratio3.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$48.0M$46.0M$53.0M$56.0M$67.0M
Operating Profit$-24.0M$-46.0M$-23.0M$-14.0M$-14.0M
Net Profit$-27.0M$-47.0M$-24.0M$-15.0M$-20.0M
EPS$-1.68$-2.77$-1.34$-0.83$-0.93
Op Margin-49.8%-101.1%-43.5%-24.5%-21.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$123.0M$86.0M$57.0M$45.0M$58.0M
Total Liabilities$39.0M$44.0M$34.0M$35.0M$41.0M
Cash$99.0M$62.0M$36.0M$22.0M$32.0M
Borrowings$28.0M$35.0M$23.0M$23.0M$26.0M

Latest News

Exagen to Announce Second Quarter Financial Results on August 4, 2026 GlobeNewswire · Jul 21, 2026 Roth Capital Initiates Exagen at Buy With $8 Price Target MT Newswires · Jun 25, 2026 Exagen (XGN) Stock Draws Fresh Price Target Split After Analysts Trim Targets Simply Wall St. · Jun 19, 2026 Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus GlobeNewswire · Jun 1, 2026 How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05% Zacks · May 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-20.0M$-32.0M$-14.0M$-13.0M$-14.0M
Investing Cash Flow$-5.0M$-9.0M$-2.0M$-1.0M$-1.0M
Financing Cash Flow$-4.0M$0$0$0$0
Net Cash Flow$42.0M$-37.0M$-26.0M$-14.0M$10.0M
Free Cash Flow$-23.0M$-36.0M$-15.0M$-14.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.34
EV / EBITDA-17.30
FCF Yield-3.84%
Quick Ratio3.18
Interest Coverage-2.58
Return 1Y-36.17%
Return 3Y60.28%
Return 5Y-67.39%

Ownership

Insiders Held27.91%
Institutions Held55.43%
Institutions Float Held76.89%
Institutional HolderSharesReport Date
Balyasny Asset Management LP796,6322026-03-31
Wexford Capital LP792,8552026-03-31
Acadian Asset Management. LLC689,1142026-03-31
Vanguard Capital Management LLC678,6522026-03-31
Nano Cap New Millennium Growth Fund L P585,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Exagen Inc.

Exagen Inc. is led by CEO John Aballi, employs 209 people, headquartered in US, publicly traded since 2019.

Exagen Inc. (XGN) stock trades at $8.42 with a market capitalization of $203.43M. The stock is valued at a price-to-earnings (P/E) ratio of -9.96, price-to-book of 16.16, price-to-sales of 2.78. Over the past 52 weeks the stock has ranged between $2.59 and $12.23, and currently trades 31.2% below its 52-week high.

On profitability, Exagen Inc. generates a return on equity (ROE) of -121.62%, return on capital employed of -34.33%, an operating margin of -20.90%, a net profit margin of -26.61%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides